
Non-profit stem cell research institute. Developing regenerative therapies for the nervous system. @neuralstemcells.bsky.social @NeuralStemCells@mstdn.science
Albany, New York
Joined July 2010
- Tweets1.6K
- Following978
- Followers3.4K
- Likes174
Check out the beautiful original art created by Dr. Yangzi Isabel Tian for the Nov 6 cover of @CellStemCell with early results from our #ClinicalTrial for RPE replacement to treat dry age-related #MacularDegeneration.
Full Text | zurl.co/gQ2bq
@isabel91775
Regenerative Research Fdn/NSCI retweeted
How close are we to using stem cell treatments for age-related macular degeneration (AMD)?
Join our Macular Chat tomorrow, October 29, with Dr. Jeffrey Stern, co-founder of @NeuralStemCells. He'll cover the latest science, share clinical trial updates, and explain what these advances mean for people living with AMD.
Listen live: bit.ly/3JvQ5C6 🔊🔊
Stem cell research is opening new doors for treating age-related #MacularDegeneration (AMD), a leading cause of vision loss.
Join our co-founders, Drs. Jeffrey Stern and Sally Temple on @BrightFocus Foundation's Macular Chat on Wed, Oct 29.
They'll break down the science, share clinical trial updates, and explain what these advances mean for people living with AMD.
Register today and ask your questions live: zurl.co/5PL54
Regenerative Research Fdn/NSCI retweeted
Less than two weeks left to register for the inaugural conference on Assembloids & Complex Cell-Cell Interactions @CSHL
Check out the topics and amazing lineup of speakers! 👇
A great piece by our friends at Michigan Medicine! We are grateful to have our first clinical trial in the skilled hands of Drs. Rajesh Rao of Kellogg Eye Center, David Liao of LA Retina and Theodore Leng of Stanford Medicine.
Article | zurl.co/0eUMo
🔊 Are you a detail-oriented PhD scientist with cell biology or #biomanufacturing experience? Interested in development of a novel clinical stage cell replacement therapy for dry age-related #MacularDegeneration (AMD)? We are #hiring!
Learn more: zurl.co/uwrDd
Today, Liz Fisher presents "PLD3 contributions to vascular dysfunction in the context of AD" during the poster session at #AAIC2025!
Poster | #107171
Time | 7:30AM – 4:15PM
Where | Exhibit Hall
Today at #AAIC2025: Taylor Bertucci presents "APOE4 alters vascular cells in cognitively normal brains and in vitro models revealing early pathogenic AD contributions of endothelial cells."
Session | Dissecting molecular disease mechanisms
Time | 2:00 – 3:30PM
Location | Hall G
Coming up at #AAIC2025, Taylor Bertucci and Liz Fisher will present data related to APOE and PLD3 contributions to vascular dysfunction in #Alzheimers Disease. Check it out!
Alzheimer's Association | zurl.co/jgQ7m
Proceedings from the 2024 Global Tau Conference are available through the @alzassociation in collaboration with @CurePSP and the #RainwaterCharitableTrust.
Full text | zurl.co/0AnwI
We were thrilled to host Dr. Kristen Brennand of @Yale this week! She gave a terrific talk on "Using Stem Cells to Explore the Genetics Underlying Brain Disease."
#Schizophrenia
#Autism
#StemCells
@kristenbrennand
Congrats to the winners and to everyone who completed the @CDPHP #WorkforceTeamChallenge!
@timesunion coverage | zurl.co/DDAjZ
We had a blast at the @CDPHP #WorkForceChallenge! Jack Huber took 2nd place overall for the 2nd year in a row and the whole team enjoyed the event.
@hack_juber
@SolTorruella
@KiehlTom
@KateTubbesing
@Swapna_Nk
What a week! Many thanks to the #ARVO2025 organizers for a terrific meeting! We loved spending time with great colleagues, catching up with old friends and hearing about so much inspiring #VisionResearch 👀 in beautiful #SaltLakeCity.
@ARVOinfo
That's a wrap! Sally Temple, Taylor Bertucci and Kate Tubbesing all spoke at the annual #NIHfunded Alzheimer's Disease Sequencing Project #FunctionalGenomics meeting at the @GladstoneInst.
#ADSP #FunGen #Alzheimers
#organoid #neurovascular
Today! Jeff Stern presents "Safety & Tolerability of RPE Stem Cell-derived RPE Implantation in Patients with Dry Age-related #MacularDegeneration: Early Low Dose Clinical Outcomes"
Session Info
Clinical advances in cell & gene therapy
8:30 - 10:15 AM
Ballroom B
#ARVO2025
Today @ #ARVO2025: Brigitte Arduini will present "Preclinical safety and efficacy of an adult progenitor cell product, RPESC-RPE-4W, as therapy for dry Age-Related #MacularDegeneration"
Session Info
Title | Stem cell and gene therapy
Time | 3:15 - 5pm (talk @ 3:15pm)
Room | 255E
We're looking forward to #ARVO2025! Brigitte Arduini will give a talk describing preclinical safety and efficacy studies that enabled an IND for our adult #stemcell therapy to treat dry Age-related #MacularDegeneration. Jeff Stern will present early Phase 1/2a clinical data.






























